Shanghai Kehua Bio-engineering Co Ltd (002022):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shanghai Kehua Bio-engineering Co Ltd (002022) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9997
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, chemiluminescence reagents; and laboratory instruments such as clinical chemistry analyzers, electrolyte analyzers, microplate readers, nucleic acid extractors and automatic chemiluminescence analyzers. It is one of the global suppliers of WHO, UNICEF, PEPFAR, and the Clinton HIV/AIDS Initiative. The company has sales supports facilities in major cities in China and it markets its products in China and across the world through distributors. KHB is headquartered in Shanghai, China.

Shanghai Kehua Bio-engineering Co Ltd (002022) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Kehua Bio-engineering Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Shanghai Kehua to Acquire Diagnostic Assets from Altergon Italia 11
Acquisition 12
Shanghai Kehua Bio-Engineering Plans to Acquire 55% Stake in Guangdong-Based Biotechnology Company for USD19.3 Million 12
KHB Shanghai Kehua Bio-Engineering Acquires Technogenetics USD20.6 Million 13
Shanghai Kehua to Acquire Technogentics from Bouty Healthcare 14
Shanghai Kehua Bio-engineering Co Ltd – Key Competitors 15
Shanghai Kehua Bio-engineering Co Ltd – Key Employees 16
Shanghai Kehua Bio-engineering Co Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Kehua Bio-engineering Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Kehua Bio-engineering Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shanghai Kehua to Acquire Diagnostic Assets from Altergon Italia 11
Shanghai Kehua Bio-Engineering Plans to Acquire 55% Stake in Guangdong-Based Biotechnology Company for USD19.3 Million 12
KHB Shanghai Kehua Bio-Engineering Acquires Technogenetics USD20.6 Million 13
Shanghai Kehua to Acquire Technogentics from Bouty Healthcare 14
Shanghai Kehua Bio-engineering Co Ltd, Key Competitors 15
Shanghai Kehua Bio-engineering Co Ltd, Key Employees 16
Shanghai Kehua Bio-engineering Co Ltd, Subsidiaries 17

List of Figures
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Kehua Bio-engineering Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Shanghai Kehua Bio-engineering Co Ltd (002022):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CryoPort Inc (CYRX)-製薬・医療分野:企業M&A・提携分析
    Summary Cryoport Inc (Cryoport) is a provider of cold chain logistics solutions for temperature-sensitive biological materials to the life science industries. It offers liquid nitrogen dry vapor shippers with advanced logistics management platform called Cryoportal, which provides credentials relate …
  • Mondelez International Inc (MDLZ):企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Dentsu, Inc.:企業の戦略・SWOT・財務分析
    Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Grand Gulf Energy Ltd (GGE):企業の財務・戦略的SWOT分析
    Summary Grand Gulf Energy Ltd (GGE), formerly Alto Energy International Ltd, is an oil and gas exploration and production company. It acquires, explores and develops conventional oil and gas assets in the US oil and gas basins. In addition, GGE also holds interests in Napoleonville Salt Dome project …
  • Sarovar Hotels Private Limited:企業の戦略・SWOT・財務情報
    Sarovar Hotels Private Limited - Strategy, SWOT and Corporate Finance Report Summary Sarovar Hotels Private Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Helen of Troy Ltd:戦略・SWOT・企業財務分析
    Helen of Troy Ltd - Strategy, SWOT and Corporate Finance Report Summary Helen of Troy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Arab Assurers Insurance Co.:企業の戦略・SWOT・財務情報
    The Arab Assurers Insurance Co. - Strategy, SWOT and Corporate Finance Report Summary The Arab Assurers Insurance Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Petroleos Mexicanos-エネルギー分野:企業M&A・提携分析
    Summary Petroleos Mexicanos (PEMEX) is a state owned vertically integrated oil and gas company. The company explores for, develops and produces crude oil and natural gas. It also refines and markets petroleum products. PEMEX gathers and processes natural gas products. It manufactures and markets a w …
  • IHI Corporation:企業の戦略・SWOT・財務分析
    IHI Corporation - Strategy, SWOT and Corporate Finance Report Summary IHI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sinovac Biotech Ltd (SVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, bilive, anflu, panflu and panflu, among others. Its healive is an inactivated hepatitis A vaccine. Sinovac Biotech’s bilive i …
  • United Community Banks Inc:企業のM&A・事業提携・投資動向
    United Community Banks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Community Banks Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • NCC Ltd (NCC):企業の財務・戦略的SWOT分析
    NCC Ltd (NCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Texas Instruments Inc.:企業の戦略・SWOT・財務分析
    Texas Instruments Inc. - Strategy, SWOT and Corporate Finance Report Summary Texas Instruments Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Information Services International-Dentsu Ltd (4812):企業の財務・戦略的SWOT分析
    Information Services International-Dentsu Ltd (4812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Nila Infrastructures Ltd
    Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Adventist Health System:企業の戦略的SWOT分析
    Adventist Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • LG International Corp (001120):企業の財務・戦略的SWOT分析
    LG International Corp (001120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Press Association:企業の戦略・SWOT・財務情報
    Press Association - Strategy, SWOT and Corporate Finance Report Summary Press Association - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Breg Inc:医療機器:M&Aディール及び事業提携情報
    Summary Breg Inc (Breg) is a medical device company that manufactures and distributes sports medicine and rehabilitation products. The company offers products such as knee braces, cold therapy, dvt prophylaxis, hip bracing, shoulder bracing, fracture bracing, elbow wrist bracing, spine bracing, foot …
  • Streamline Health Solutions Inc (STRM):企業の財務・戦略的SWOT分析
    Summary Streamline Health Solutions Inc (Streamline Health) is a medical technology company that offers patient engagement and SaaS-based solutions. The company provides solutions including HIM, patient engagement, patient care, coding and CDI, and financial management solutions. It offers its patie …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆